Question to the Department of Health and Social Care:
To ask Her Majesty's Government what discussions have been held between the Department of Health and Social Care and the Department for Business, Energy and Industrial Strategy about the impact of the fee structure introduced by SecurMed, the UK’s National Medicines Verification Organisation, on small and medium-sized enterprises.
There have been no specific discussions about the impact of SecurMed’s fee structure.
The Department and the Medicines and Healthcare products Regulatory Agency are responsible for supervising SecurMed and ensuring that they are complying with the regulation in a fair and proportionate way.